Homepage

EFIL – return to life® reunites the performance of Sirolimus drug with long-term advantages of a safe biodegradable polymer based drug delivery matrix released from a thin strut Co-Cr stent system.

• Hybrid and flexible stent design.
• Thin strut cobalt chromium stent with surface modification for better drug delivery.
• Uniform drug coating on abluminal surface using patented stent coating technology for drug release only to targeted tissue.
• Highly safe biodegradable polymer matrix.
• Protective top coat ensures better polymer-drug binding with negligible polymer flaking during stent expansion.
• Biodegradable polymer matrix completely degrades in 6 – 9 months leaving behind bare metal stent.